This article is republished from The Conversation under a Creative Commons license. Read the original article here. There was a brief moment of euphoria last week, when it seemed that COVID-19 vaccines, medicines and supplies might be liberated from the World Trade Organization’s intellectual property rights straitjacket and a patent waiver would make them available…

Read More